JAK2 V617F Mutation Analysis

There are no preparation instructions.

$454.95
Add to

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

JAK2 V617F MUTATION ANALYSIS #92473

11 Biomarkers - Specimen Type: Varied - Process Time*: Average 6 to 7 business days

Biomarkers 11

AMINO ACIDS

ASSAY DETAILS

Clinical Indication

EXON

GENE RESULTS

INTERPRETATION

JAK2 V617F MUTATION

MUTATION FREQUENCY

MUTATION TYPE

NUCLEOTIDE CHANGE

REFERENCE

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The JAK2 V617F Mutation Analysis test contains 1 test with 11 biomarkers .

Clinical Significance

JAK2 V617F Mutation Analysis - This DNA-based assay tests leukocytes from blood or bone marrow aspirate for mutation at codon 617 of JAK2, using an advanced DNA sequencing method. The JAK2 V617F mutation is associated with myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and primary myelofibrosis.

Methodology

Polymerase Chain Reaction-based DNA Sequencing

Alternative Name(s)

Myeloproliferative neoplasm,PMF,Essential Thrombocythemia (ET),Polycythemia Vera (PV),ET,Primary Myelofibrosis (PMF),PV